Benchtop and Initial Clinical Evaluation of the ShockPulse Stone Eliminator in Percutaneous Nephrolithotomy
Benchtop and Initial Clinical Evaluation of the ShockPulse Stone Eliminator in Percutaneous Nephrolithotomy
复制标题
DOI:
10.1089/end.2016.0664
复制
发表时间:
2017-02-01
影响因子:
2.7
通讯作者:
Lange, Dirk
中科院分区:
文献类型:
--
作者:
Chew, Ben H.;Matteliano, Andre A.;Lange, Dirk
Purpose: Standardized bench testing of the new ShockPulse (TM) intracorporeal lithotripter was performed against three commercially available lithotripsy systems to determine differences and nuances in performance.Materials and Methods: The ShockPulse intracorporeal lithotripter was tested against the LUS-2 (TM), CyberWand (TM), and EMS LithoClast (TM) in a standardized bench setting using hard (Ultracal-30) and soft (plaster of Paris) stone phantoms. An in vitro kidney model was used to record the time needed to fragment stone samples into retrievable-sized pieces. The time needed to fully comminute and evacuate stone samples was also recorded. The efficacy of each device at various applied pressures was determined using a hands-free apparatus, which was used to apply 1.0, 1.5, and 2.0 pounds of fixed force.Results: For hard and soft stones, the time needed to create retrievable fragments was similar among all systems (p=0.585). The ShockPulse was significantly faster than the LUS-2 and LithoClast at fully fragmenting and evacuating stone samples (p=0.046), while the CyberWand was significantly slower than all three systems at this task (p=0.001). When fixed forces were applied to a large stone phantom, the ShockPulse and CyberWand were significantly faster than the LUS-2 and LithoClast (p